Command Palette

Search for a command to run...

Clinical Trials · NCT03449654

Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes

CompletedPhase 4Liraglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Steno Diabetes Center Copenhagen
Enrollment
102
Start date
Oct 2017
Locations
1 site, Denmark
Primary endpoint
Change in vascular inflammation
View Liraglutide compound reference